← Back to directory

Christian Meier

Researcher Next ID · RN-044528

Researcher · Biochemistry, Genetics and Molecular Biology

University of Basel

Basel, Chile

Accepting doctoral researchersFunding unknown
Works count
381
Citation count
9,748
H-index
51
i10-index
125

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Bone health and osteoporosis research
Bone health and treatments
Pulmonary Hypertension Research and Treatments
Bone Metabolism and Diseases
Thyroid Disorders and Treatments

Publications

  • Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

    The Lancet Respiratory Medicine · 2021 · 10.1016/s2213-2600(20)30532-4

  • Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS

    The Journal of Clinical Endocrinology & Metabolism · 2020 · https://doi.org/10.1210/clinem/dgaa756

  • Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

    European Respiratory Journal · 2019 · 10.1183/13993003.02004-2018

  • RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors

    European Respiratory Journal · 2017 · 10.1183/13993003.02425-2016

  • Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2

    Annals of the Rheumatic Diseases · 2016 · 10.1136/annrheumdis-2015-209087

  • Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial

    The Lancet Respiratory Medicine · 2016 · 10.1016/s2213-2600(16)30022-4

  • Effects of diabetes drugs on the skeleton

    Bone · 2015 · 10.1016/j.bone.2015.04.026

  • Use of Antidiabetic Agents and the Risk of Pancreatic Cancer: A Case–Control Analysis

    The American Journal of Gastroenterology · 2012 · 10.1038/ajg.2011.483

  • Antiepileptics and bone health

    Therapeutic Advances in Musculoskeletal Disease · 2011 · 10.1177/1759720x11410769

  • Use of metformin and the risk of ovarian cancer: A case–control analysis

    Gynecologic Oncology · 2011 · 10.1016/j.ygyno.2011.06.038

  • Parathyroid hormone analogues in the treatment of osteoporosis

    Nature Reviews Endocrinology · 2011 · 10.1038/nrendo.2011.108

  • Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer

    Diabetes Care · 2010 · 10.2337/dc09-1791

  • Use of Thiazolidinediones and Fracture Risk

    Archives of Internal Medicine · 2008 · 10.1001/archinte.168.8.820

  • Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia

    Diabetes Care · 2008 · 10.2337/dc08-1171

  • Endogenous Sex Hormones and Incident Fracture Risk in Older Men The Dubbo Osteoporosis Epidemiology Study

    Archives of Internal Medicine · 2008 · 10.1001/archinternmed.2007.2

  • Local adipose tissue depots as cardiovascular risk factors

    Cardiovascular Research · 2007 · 10.1016/j.cardiores.2007.03.008

  • Age-Related Changes in Serum Testosterone and Sex Hormone Binding Globulin in Australian Men: Longitudinal Analyses of Two Geographically Separate Regional Cohorts

    The Journal of Clinical Endocrinology & Metabolism · 2007 · 10.1210/jc.2007-0862

  • Bone Resorption and Osteoporotic Fractures in Elderly Men: The Dubbo Osteoporosis Epidemiology Study

    Journal of Bone and Mineral Research · 2005 · 10.1359/jbmr.041207

  • Supplementation With Oral Vitamin D3 and Calcium During Winter Prevents Seasonal Bone Loss: A Randomized Controlled Open-Label Prospective Trial

    Journal of Bone and Mineral Research · 2004 · 10.1359/jbmr.040511

  • Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial

    Atherosclerosis · 2003 · 10.1016/s0021-9150(02)00372-6

  • Prospective Study of the Spontaneous Course of Subclinical Hypothyroidism: Prognostic Value of Thyrotropin, Thyroid Reserve, and Thyroid Antibodies

    The Journal of Clinical Endocrinology & Metabolism · 2002 · 10.1210/jcem.87.7.8678

  • TSH-Controlled l -Thyroxine Therapy Reduces Cholesterol Levels and Clinical Symptoms in Subclinical Hypothyroidism: A Double Blind, Placebo-Controlled Trial (Basel Thyroid Study)

    The Journal of Clinical Endocrinology & Metabolism · 2001 · 10.1210/jcem.86.10.7973

  • TSH-Controlled L-Thyroxine Therapy Reduces Cholesterol Levels and Clinical Symptoms in Subclinical Hypothyroidism: A Double Blind, Placebo-Controlled Trial (Basel Thyroid Study)

    The Journal of Clinical Endocrinology & Metabolism · 2001 · 10.1210/jc.86.10.4860

  • Glycoprotein-associated amino acid exchangers: broadening the range of transport specificity

    Pflügers Archiv - European Journal of Physiology · 2000 · 10.1007/s004240000274

  • Between Republic and Empire

    · 1990 · 10.1525/9780520914513

Current projects

    No projects listed.